RETRACTED: miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9 (Retracted article. See vol. 49, pg. 29, 2023)

被引:21
作者
Zheng, Hong [1 ]
Wu, Jianbo [2 ]
Shi, Jiachen [3 ]
Lu, Chunya [3 ]
Wang, Yuanyuan [2 ]
Sun, Qianqian [2 ]
Zhang, Guojun [3 ]
Zhao, Guoqiang [2 ]
机构
[1] Henan Univ, Inst Mol Med, Dept Pathophysiol, Med Coll, Kaifeng 475004, Henan, Peoples R China
[2] Zhengzhou Univ, Sch Basic Med Sci, 100 Kexue Rd, Zhengzhou 450001, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Resp Med, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
关键词
lung adenocarcinoma; miR-125a-5p; proliferation; apoptosis; NEDD9; MICRORNA SIGNATURES; CANCER; INVASION; METASTASIS; EXPRESSION; GROWTH;
D O I
10.3892/or.2017.5812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are critical translational regulators that act as oncogenes or tumor-suppressor genes. qRT-PCR assay results showed that the expression levels of miR-125a-5p are lower in lung adenocarcinoma (AD) tissues than expression levels in adjacent non-neoplastic tissues. This relative expression was found to be significantly associated with lymph node metastases. Cell growth, apoptosis, caspase activity and Transwell invasion assay results showed that in two lung adenocarcinoma cell lines transfected with a miR-125a-5p mimic, proliferation and invasion rates were found to be significantly reduced, whereas the apoptosis rate of the miR-125a-5p mimic group was enhanced. Subsequent western blotting and luciferase reporter assays showed that miR-125a-5p is able to bind to putative binding sites within the mRNA 3' untranslated region (UTR) of neural precursor cell expressed, developmentally downregulated 9 (NEDD9). Our findings suggest that miR-125a-5p may serve as a therapeutic agent for lung adenocarcinoma through its major target, NEDD9.
引用
收藏
页码:1790 / 1796
页数:7
相关论文
共 35 条
  • [1] Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells
    Abdelrahim, M
    Smith, R
    Burghardt, R
    Safe, S
    [J]. CANCER RESEARCH, 2004, 64 (18) : 6740 - 6749
  • [2] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [3] Ectopic Expression of MiR-125a Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting MMP11 and VEGF
    Bi, Qian
    Tang, Shanhong
    Xia, Lin
    Du, Rui
    Fan, Rui
    Gao, Liucun
    Jin, Jiang
    Liang, Shuhui
    Chen, Zheng
    Xu, Guanghui
    Nie, Yongzhan
    Wu, Kaichun
    Liu, Jie
    Shi, Yongquan
    Ding, Jie
    Fan, Daiming
    [J]. PLOS ONE, 2012, 7 (06):
  • [4] Towards a complete description of the microRNA complement of animal genomes
    Brennecke, J
    Cohen, SM
    [J]. GENOME BIOLOGY, 2003, 4 (09)
  • [5] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [6] MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
    Chan, JA
    Krichevsky, AM
    Kosik, KS
    [J]. CANCER RESEARCH, 2005, 65 (14) : 6029 - 6033
  • [7] Expression and clinical significance of NEDD9 in lung tissues
    Chang, Jing-Xia
    Gao, Feng
    Zhao, Guo-Qiang
    Zhang, Guo-Jun
    [J]. MEDICAL ONCOLOGY, 2012, 29 (04) : 2654 - 2660
  • [8] Cancer Incidence And Mortality in China, 2006
    Chen, Wan-qing
    Zhang, Si-wei
    Zou, Xiao-nong
    Zhao, Ping
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2011, 23 (01) : 3 - 9
  • [9] THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR-SP1 BINDS TO UPSTREAM SEQUENCES IN THE SV40 EARLY PROMOTER
    DYNAN, WS
    TJIAN, R
    [J]. CELL, 1983, 35 (01) : 79 - 87
  • [10] Medical progress - Esophageal cancer
    Enzinger, PC
    Mayer, RJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) : 2241 - 2252